As of 2024-12-15, the Relative Valuation of Isracann Biosciences Inc (IPOT.CN) is (0.00) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.02 CAD, the upside of Isracann Biosciences Inc based on Relative Valuation is -117.3%.
The range of the Relative Valuation is (0.00) - (0.02) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 0.1x - 1.2x | 0.1x |
| Forward P/E multiples | -0.0x - 0.9x | 0.1x |
| Fair Price | (0.00) - (0.02) | (0.00) |
| Upside | -113.8% - -252.0% | -117.3% |
| Date | P/E |